高度功能障碍急性冠状动脉综合征患者的指导医学治疗和住院死亡率:两项全国性回顾性队列研究的分析
Zhengyang Jin1, Geru Aa1, Yifan Guo1
1Department of Cardiology, Tianjin Medical University General Hospital, Tianjin, Tianjin, China.
BMJ open
|August 26, 2025
概括
在急性冠状动脉综合征 (ACS) 患者中,指导性医疗疗 (GDMT) 显著降低了住院死亡率. 早期使用GDMT,包括β抑制剂,ACE抑制剂/ARB,双抗血小板剂和他类药物,对于改善结果至关重要.
科学领域:
- 心脏病学
- 肝脏病学
- 临床医学
背景情况:
- 患有晚期功能障碍 (eGFR < 30 mL/ min/ 1. 73 m2) 的急性冠状动脉综合征 (ACS) 患者面临高住院死亡风险.
- 包括β- 阻断剂,ACE抑制剂/血管新生素受体阻断剂,双抗血小板剂和他类药物在内的指导性医疗治疗是ACS的标准治疗方法.
- 在患有严重功能障碍的ACS患者中早期GDMT的益处仍然是研究领域.
研究的目的:
- 评估指导医学治疗 (GDMT) 对急性冠状动脉综合征 (ACS) 晚期功能障碍患者住院死亡率的影响.
- 确定是否结合使用β抑制剂,ACE抑制剂/血管新生素受体抑制剂,双抗血小板药物和他类药物可以改善这一高危人群的生存率.
主要方法:
- 从2014年到2019年利用中国两个大型多中心观察队伍 (CNEDSSP和CCC-ACS) 的数据进行了回顾性队列研究.
- 包括6260名患有晚期功能障碍的ACS患者 (eGFR<30毫升/ 分钟/ 1. 73米2),
- 根据在住院24小时内服用所有四种GDMT成分的情况对患者进行分类.
主要成果:
- 对两组患者的综合分析显示,早期GDMT显著降低了住院死亡率 (RR: 0. 62,95% CI: 0. 47至0. 81).
- 患有心肌梗塞 (MI) 患者在早期GDMT治疗中出现更明显的死亡率降低 (合并RR: 0. 39,95%CI: 0. 27至0. 58).
- 在晚期功能障碍和心脏病发作的GDMT使用者中,观察到住院死亡率降低了61%.
结论:
- 早期启动指导性治疗 (GDMT) 与晚期功能障碍患者的住院死亡率大幅降低有关.
- 这些发现强调了及时和全面的GDMT在改善ACS患者的生存率方面的重要性,特别是那些功能受损患者.
- 这项全国性研究提供了强有力的证据,支持在晚期功能障碍患者中积极使用GDMT.
相关概念视频
01:20Acute Kidney Injury V: Interprofessional Care
44
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:22Acute Kidney Injury VI: Nursing Management
57
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
57
01:28Chronic Kidney Disease III: Interprofessional Care
78
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
78
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:11Renal Failure: Dose Adjustments
153
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
153